NCT01477879

Hsv 1 and 2 Gowey Protocol Versus Placebo

Phase II Clinical Trial of Versabase/Sarracenia Purpurea Versus Placebo

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 33 (actual)
• Sponsor: Naturopaths International · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.

Detailed description

Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.

Conditions

• Herpes

Interventions

Type	Name	Description
OTHER	Versabase gel with sarracenia purpurea 20% liquid extract	Topical application of gel/plant mix to lesions
OTHER	placebo (versabase gel only)	versabase gel only

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-03-01
• Completion: 2011-03-01
• First posted: 2011-11-23
• Last updated: 2011-11-23

Locations

1 site across 1 country: United States